Güven DC - Search Results

1

Clinical outcomes of cyclin-dependent kinase 4-6 (CDK 4-6) inhibitors in patients with male breast cancer: A multicenter study.

Yıldırım HÇ, Mutlu E, Chalabiyev E, Özen M, Keskinkılıç M, Ön S, Çelebi A, Dursun B, Acar Ö, Kahraman S, Aykan MB, Kaman Ö, Doğan A, Erdoğan AP, Melisa Celayir Ö, Günenç D, Güven DC, Vedat Bayoğlu İ, Yavuzşen T, Hacıbekiroğlu İ, İnanç M, Kılıçkap S, Yalçın Ş, Aksoy S. Yıldırım HÇ, et al. Among authors: guven dc. Breast. 2022 Dec;66:85-88. doi: 10.1016/j.breast.2022.09.009. Epub 2022 Sep 30. Breast. 2022. PMID: 36208540 Free PMC article.

2

Analysis of Fusobacterium nucleatum and Streptococcus gallolyticus in saliva of colorectal cancer patients.

Guven DC, Dizdar O, Alp A, Akdoğan Kittana FN, Karakoc D, Hamaloglu E, Lacin S, Karakas Y, Kilickap S, Hayran M, Yalcin S. Guven DC, et al. Biomark Med. 2019 Jun;13(9):725-735. doi: 10.2217/bmm-2019-0020. Epub 2019 Jun 3. Biomark Med. 2019. PMID: 31157977

3

Complete responses to two different anti-PD1 agents in a metastatic melanoma patient.

Kilickap S, Guven DC, Aktepe OH, Aktas BY, Dizdar O. Kilickap S, et al. Among authors: guven dc. J Oncol Pharm Pract. 2020 Mar;26(2):496-499. doi: 10.1177/1078155219858657. Epub 2019 Jun 29. J Oncol Pharm Pract. 2020. PMID: 31256744

4

Gut microbiota and cancer immunotherapy: prognostic and therapeutic implications.

Guven DC, Aktas BY, Simsek C, Aksoy S. Guven DC, et al. Future Oncol. 2020 Mar;16(9):497-506. doi: 10.2217/fon-2019-0783. Epub 2020 Feb 26. Future Oncol. 2020. PMID: 32100550 Review.

5

COVID-19 pandemic: changes in cancer admissions.

Guven DC, Aktas BY, Aksun MS, Ucgul E, Sahin TK, Yildirim HC, Guner G, Kertmen N, Dizdar O, Kilickap S, Aksoy S, Yalcin S, Turker A, Uckun FM, Arik Z. Guven DC, et al. BMJ Support Palliat Care. 2020 Jul 14:bmjspcare-2020-002468. doi: 10.1136/bmjspcare-2020-002468. Online ahead of print. BMJ Support Palliat Care. 2020. PMID: 32665259

6

The use of CDK 4/6 inhibitors in the adjuvant treatment of breast cancer: Timing matters.

Guven DC, Sahin TK, Aksoy S. Guven DC, et al. Breast J. 2020 Dec;26(12):2435-2436. doi: 10.1111/tbj.14027. Epub 2020 Aug 19. Breast J. 2020. PMID: 32812288 No abstract available.

7

Evaluation of emergency departments visits in patients treated with immune checkpoint inhibitors.

Guven DC, Sahin TK, Aksun MS, Taban H, Aktepe OH, Aksu NM, Akkaş M, Erman M, Kilickap S, Dizdar O, Aksoy S. Guven DC, et al. Support Care Cancer. 2021 Apr;29(4):2029-2035. doi: 10.1007/s00520-020-05702-8. Epub 2020 Aug 26. Support Care Cancer. 2021. PMID: 32851486

8

Perspectives, Knowledge, and Fears of Cancer Patients About COVID-19.

Guven DC, Sahin TK, Aktepe OH, Yildirim HC, Aksoy S, Kilickap S. Guven DC, et al. Front Oncol. 2020 Aug 28;10:1553. doi: 10.3389/fonc.2020.01553. eCollection 2020. Front Oncol. 2020. PMID: 33014800 Free PMC article.

9

Predictive biomarkers for immunotherapy efficacy in non-small-cell lung cancer: current status and future perspectives.

Guven DC, Sahin TK, Dizdar O, Kilickap S. Guven DC, et al. Biomark Med. 2020 Oct;14(14):1383-1392. doi: 10.2217/bmm-2020-0310. Epub 2020 Oct 16. Biomark Med. 2020. PMID: 33064030 Review.

10

Chemoimmunotherapy for the salvage treatment of Ewing sarcoma: A case report.

Guven DC, Kilickap S, Yildirim HC, Ceylan F, Bas O, Dizdar O. Guven DC, et al. J Oncol Pharm Pract. 2021 Jul;27(5):1281-1283. doi: 10.1177/1078155220965677. Epub 2020 Oct 18. J Oncol Pharm Pract. 2021. PMID: 33070764

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

154 results

Search Page

Filters